Janus Henderson Investors US’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
$28.7M Sell
434,083
-1,885
-0.4% -$124K 0.02% 545
2016
Q4
$27.6M Buy
435,968
+103,051
+31% +$6.53M 0.02% 559
2016
Q3
$21.2M Sell
332,917
-60
-0% -$3.82K 0.02% 578
2016
Q2
$24.8M Buy
332,977
+4,689
+1% +$349K 0.02% 538
2016
Q1
$21.9M Sell
328,288
-3,876
-1% -$259K 0.02% 569
2015
Q4
$22.5M Sell
332,164
-47,808
-13% -$3.23M 0.02% 584
2015
Q3
$20.3M Buy
379,972
+58,958
+18% +$3.15M 0.02% 606
2015
Q2
$20.2M Buy
321,014
+197,423
+160% +$12.4M 0.02% 602
2015
Q1
$5.95M Buy
+123,591
New +$5.95M ﹤0.01% 768